Advertisement
IXJ vs TMED
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IXJ is a StrongBuy and TMED is a StrongBuy.
IXJ in upward trend: 10-day moving average moved above 50-day moving average on October 19, 2026
The 10-day moving average for IXJ crossed bullishly above the 50-day moving average on October 19, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 12 of 12 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 90%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 14, 2026. You may want to consider a long position or call options on IXJ as a result. In 68 of 92 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 74%.
The Moving Average Convergence Divergence (MACD) for IXJ just turned positive on October 12, 2026. Looking at past instances where IXJ's MACD turned positive, the stock continued to rise in 41 of 49 cases over the following month. The odds of a continued upward trend are 84%.
IXJ moved above its 50-day moving average on October 14, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +4.38% 3-day Advance, the price is estimated to grow further. Considering data from situations where IXJ advanced for three days, in 260 of 324 cases, the price rose further within the following month. The odds of a continued upward trend are 80%.
Bearish Trend Analysis
The RSI Indicator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 7 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where IXJ declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 77%.
IXJ broke above its upper Bollinger Band on October 20, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for IXJ entered a downward trend on October 12, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Momentum Indicator for TMED turns positive, indicating new upward trend
TMED saw its Momentum Indicator move above the 0 level on October 20, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 18 similar instances where the indicator turned positive. In 18 of the 18 cases, the stock moved higher in the following days. The odds of a move higher are at 90%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Moving Average Convergence Divergence (MACD) for TMED just turned positive on October 15, 2026. Looking at past instances where TMED's MACD turned positive, the stock continued to rise in 15 of 16 cases over the following month. The odds of a continued upward trend are 90%.
Following a +3.29% 3-day Advance, the price is estimated to grow further. Considering data from situations where TMED advanced for three days, in 69 of 75 cases, the price rose further within the following month. The odds of a continued upward trend are 90%.
Bearish Trend Analysis
The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where TMED declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 75%.
TMED broke above its upper Bollinger Band on October 20, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for TMED entered a downward trend on October 13, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
| IXJ | TMED | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 83% | N/A |
| Stochastic ODDS (%) | 1 day ago 76% | 1 day ago 76% |
| Momentum ODDS (%) | 1 day ago 74% | 1 day ago 90% |
| MACD ODDS (%) | 1 day ago 84% | 1 day ago 90% |
| TrendWeek ODDS (%) | 1 day ago 79% | 1 day ago 87% |
| TrendMonth ODDS (%) | 1 day ago 80% | 1 day ago 74% |
| Advances ODDS (%) | 8 days ago 80% | 3 days ago 90% |
| Declines ODDS (%) | 4 days ago 77% | 10 days ago 75% |
| BollingerBands ODDS (%) | 1 day ago 79% | 1 day ago 67% |
| Aroon ODDS (%) | 1 day ago 89% | 1 day ago 56% |
Advertisement
IXJ and
Correlation & Price change
A.I.dvisor indicates that over the last year, IXJ has been closely correlated with LLY. These tickers have moved in lockstep 70% of the time. This A.I.-generated data suggests there is a high statistical probability that if IXJ jumps, then LLY could also see price increases.
TMED and
Correlation & Price change
A.I.dvisor tells us that TMED and BNTX have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that TMED and BNTX's prices will move in lockstep.
| Ticker / NAME | Correlation To TMED | 1D Price Change % | ||
|---|---|---|---|---|
| TMED | 100% | +0.79% | ||
| BNTX - TMED | 31% Poorly correlated | -1.77% | ||
| PCVX - TMED | 22% Poorly correlated | -0.60% | ||
| SDGR - TMED | 22% Poorly correlated | -5.44% | ||
| CELC - TMED | 22% Poorly correlated | +6.51% | ||
| BIIB - TMED | 22% Poorly correlated | +5.34% | ||
More | ||||